MRI radiomics in the prediction of therapeutic response to neoadjuvant therapy for locoregionally advanced rectal cancer: a systematic review

References

• Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival and risk factors. Prz Gastroenterol. 2019;14(2):89–103.
   PubMed Web of Science ®Google Scholar
• Gerard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: results of the Phase III Trial ACCORD 12/0405-Prodige 2. J clin oncol. 2010;28(10):1638–1644.
   PubMed Web of Science ®Google Scholar
• Moreno CC, Sullivan PS, Mittal PKMRI. Evaluation of Rectal Cancer: staging and Restaging. Curr Probl Diagn Radiol. 2017;46(3):234–241.
   PubMed Web of Science ®Google Scholar
• Panagiotopoulou IG. Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer: does Time to Surgery Matter? Int Surg. 2015;100(6):968–973.
   PubMed Web of Science ®Google Scholar
• Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711–717.
   PubMed Web of Science ®Google Scholar
• van der Valk MJM, Hilling DE, Bastiaannet E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537–2545. .
   PubMed Web of Science ®Google Scholar
• Dayde D, Tanaka I, Jain R, et al. Predictive and prognostic molecular biomarkers for response to neoadjuvant chemoradiation in rectal cancer. Int J Mol Sci. 2017;18(3):573.
   PubMed Web of Science ®Google Scholar
• Agostini M, Crotti S, Bedin C, et al. Predictive response biomarkers in rectal cancer neoadjuvant treatment. Front Biosci (Schol Ed). 2014;6:110–119.
   Google Scholar
• Repetto O, De Re V, De Paoli A, et al. Identification of protein clusters predictive of tumour response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy. Oncotarget. 2017;8(17):28328–28341. .
   PubMedGoogle Scholar
• Horvat N, Bates DDB, Petkovska I. Novel imaging techniques of rectal cancer: what do radiomics and radiogenomics have to offer? A literature review. Abdom Radiol. 2019;(11). Doi:10.1007/s00261-019-02042-y. [Epub ahead of print].
   Web of Science ®Google Scholar
• Rizzo S, Botta F, Raimondi S, et al. Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp. 2018;2(1):36. .
   PubMedGoogle Scholar
• Guo Y, Hu Y, Qiao M, et al. Radiomics analysis on ultrasound for prediction of biologic behaviour in breast invasive ductal carcinoma. Clin Breast Cancer. 2018;18(3):e335–e344.
   PubMed Web of Science ®Google Scholar
• Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563–577.
   PubMed Web of Science ®Google Scholar
• Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–446. .
   PubMed Web of Science ®Google Scholar
• Liang CY, Chen MR, Zhao XX, et al. Multiple mathematical models of diffusion-weighted magnetic resonance imaging combined with prognostic factors for assessing the response to neoadjuvant chemotherapy and radiation therapy in locally advanced rectal cancer. Eur J Radiol. 2019;110:249–255.
   PubMed Web of Science ®Google Scholar
• Shi L, Zhang Y, Nie K, et al. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI. Magn Reson Imaging. 2019;61:33–40. . Epub 2019 May 3
   PubMed Web of Science ®Google Scholar
• Bates DDB, Mazaheri Y, Lobaugh S, et al. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer. Abdom Radiol. 2019; DOI:10.1007/s00261-019-02073-5.. [Epub ahead of print].
   Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. PRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269. . W64
   PubMed Web of Science ®Google Scholar
• Boldrini L, Cusumano D, Chiloiro G, et al. Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach. Radiol Med. 2019;124(2):145–153. 10.1007/s11547-018-0951-y.
   PubMed Web of Science ®Google Scholar
• Trakarnsanga A, Gonen M, Shia J, et al. Comparison of tumour regression grade systems for locally advanced rectal cancer after multimodality treatment. J Natl Cancer Inst. 2014;106(10):dju248.
   PubMedGoogle Scholar
• Wells G, Shea B, O’Connell J, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. 2011.[Website]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Available from: URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
   Google Scholar
• Review Manager (RevMan) [Computer program]. 5.3 ed. Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration; 2014.
   Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5. Doi:10.1186/1471-2288-5-13
   Google Scholar
• Gurses B, Boge M, Altinmakas E, et al. Multiparametric MRI in rectal cancer. Diagnostic and Interventional Radiology.2019; 25:175–182.
   Google Scholar
• Sun Y, Reynolds HM, Parameswaran B, et al. Multiparametric MRI and radiomics in prostate cancer: a review. Australas Phys Eng Sci Med. 2019;42(1):3–25.
   PubMed Web of Science ®Google Scholar
• Aggarwal N, Agrawal RK. First and second order statistics features for classification of magnetic resonance brain images. J Signal Inf Process. 2012;3:146–153.
   Google Scholar
• Zwanenburg A, Leger S, Vallieres M, et al. Image biomarker standardisation initiative. 2018 [cited 2019 Dec 30]. https://arxiv.org/abs/1612070032016
   Google Scholar
• Parekh VS, Jacobs MA. Deep learning and radiomics in precision medicine. Expert Rev Precis Med Drug Dev. 2019;5(2):59–72.
   Google Scholar
• Pyradiomics. Radiomic features [2016] [cited 2020 Jan 21] . Available from: https://pyradiomics.readthedocs.io/en/latest/features.html.
   Google Scholar
• De Vries A, Griebel J, Kremser C, et al., Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. Radiology. 217(2): 385–391. 2000. .
   PubMed Web of Science ®Google Scholar
• Devries AF, Griebel J, Kremser C, et al. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res. 2001;61(6):2513–2516.
   PubMed Web of Science ®Google Scholar
• George ML, Dzik-Jurasz AS, Padhani AR, et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg. 2001;88(12):1628–1636. .
   PubMed Web of Science ®Google Scholar
• Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 2002;360(9329):307–308. .
   PubMed Web of Science ®Google Scholar
• DeVries AF, Kremser C, Hein PA, et al. Tumour microcirculation and diffusion predict therapy outcome for primary rectal cancer. Int J Radiat Oncol Biol Phys. 2003;56(4):958–965. .
   PubMed Web of Science ®Google Scholar
• Kim YH, Kim DY, Kim TH, et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys. 2005;62(3):761–768. .
   PubMed Web of Science ®Google Scholar
• Kremser C, Trieb T, Rudisch A, et al. Dynamic T(1) mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis. J Magn Reson Imaging. 2007;26(3):662–671.
   PubMed Web of Science ®Google Scholar
• Kim NK, Baik SH, Min BS, et al. A comparative study of volumetric analysis, histopathologic downstaging, and tumour regression grade in evaluating tumour response in locally advanced rectal cancer following preoperative chemoradiation. Int J Radiat Oncol Biol Phys. 2007;67(1):204–210. .
   PubMed Web of Science ®Google Scholar
• Lambrecht M, Deroose C, Roels S, et al. The use of FDG-PET and diffusion-weighted magnetic resonance imaging for response prediction before, during. And after preoperative chemoradioterhapy for rectal cancer. Acta Oncol. 2010;49(7):956–963.
   PubMed Web of Science ®Google Scholar
• Sun YS, Zhang XP, Tang L, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: a preliminary analysis of diffusion-weighted MR imaging for early detection of tumour histopathologic downstaging. Radiology. 2010;254(1):170–178. .
   PubMed Web of Science ®Google Scholar
• Curvo-Semedo L, Lambregts DM, Maas M, et al. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy- conventional MR volumetry versus diffusion-weighted MR imaging. Radiology. 2011;260(3):734–743. .
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee JY, Lee JM, et al. Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol. 2011;21(5):987–995.
   PubMed Web of Science ®Google Scholar
• Kim YC, Lim JS, Keum KC, et al. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer. J Magn Reson Imaging. 2011;34(3):570–576. .
   PubMed Web of Science ®Google Scholar
• Engin G, Sharifov R, Gural Z, et al. Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer. Diagn Interv Radiol. 2012;18(6):574–581.
   PubMed Web of Science ®Google Scholar
• Ippolito D, Monguzzi L, Guerra L, et al. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Abdom Imaging. 2912;37(6):1032–1040. .
   Google Scholar
• Nougaret S, Rouanet P, Molinari N, et al. MR volumetry measurement of low rectal cancer helps predict tumour response and outcome after combined chemotherapy and radiation therapy. Radiology. 2012;263(2):409–418. .
   PubMed Web of Science ®Google Scholar
• Lambrecht M, Vandecaveye V, De Keyzer F, et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys. 2012;82(2):863–870. .
   PubMed Web of Science ®Google Scholar
• Jung SH, Heo SH, Kim JW, et al. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging. J Magn Reson Imaging. 2012;35(1):110–116. .
   PubMed Web of Science ®Google Scholar
• Lim JS, Kim D, Baek SE, et al. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol. 2012;22(8):1693–1700.
   PubMed Web of Science ®Google Scholar
• Barbaro V, Vitale R, Valentini V, et al. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(2):594–599.
   Google Scholar
• Monguzzi L, Ippolito D, Bernasconi DP, et al. Locally advanced rectal cancer: value of ADC mapping in prediction of tumour response to radiochemotherapy. Eur J Radiol. 2013;82(2):234–240.
   PubMed Web of Science ®Google Scholar
• Oberholzer K, Menig M, Pohlmann A, et al. Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2013;38(1):119–126. .
   PubMed Web of Science ®Google Scholar
• Cai G, Xu Y, Zhu J, et al. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation. World J Gastroenterol. 2013;19(33):5520–5527. .
   PubMed Web of Science ®Google Scholar
• Genovesi D, Filippone A, Ausili Cefaro G, et al. Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstituional prospective study. Eur J Surg Oncol. 2913;39(10):1071–1078. .
   Google Scholar
• Kluza E, Rozeboom ED, Maas M, et al. T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer. Eur Radiol. 2013;23(1):253–261. .
   PubMed Web of Science ®Google Scholar
• Yu SK, Tait D, Chau I, et al. MRI predictive factors for tumour response in rectal cancer following neoadjuvant chemoradiation therapy – implications for induction chemotherapy? Int J Radiat Oncol Biol Phys. 2013;87(3):505–511.
   PubMed Web of Science ®Google Scholar
• Musio D, De Felice F, Magnante AL, et al. Diffusion-weighted magnetic resonance application in response prediction before, during and after neoadjuvant radiochemotherapy in primary rectal cancer carcinoma. Biomed Res Int. 2013;2013:740195.
   PubMed Web of Science ®Google Scholar
• Elmi A, Hedgire SS, Covarrubias D, et al. Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer. Clin Radiol. 2013;68(10):e524–31.
   PubMed Web of Science ®Google Scholar
• Ha HI, Kim AY, Yu CS, et al. Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy. Eur Radiol. 2013;23(12):3345–3353.
   PubMed Web of Science ®Google Scholar
• Intven M, Reerink O, Philippens ME. Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neo-adjuvant radiochemotherapy. Strathlenther Onkol. 2013;189(2):117–122.
   PubMed Web of Science ®Google Scholar
• Lee EM, Hong YS, Kim KP, et al. Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer. Cancer Sci. 2013;104(1):111–115. .
   PubMed Web of Science ®Google Scholar
• De Vries AF, Piringer G, Kremser C, et al. Pretreatement evaluation of microcirculation by dynamic contrast-enhanced magnetic resonance imaging predicts survival in primary rectal cancer patients. Int J Radiat Oncol Biol Phys. 2014;90(5):1161–1167. .
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee JM, Gupta SN, et al. Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer. J Magn Reson Imaging. 2014;40(3):730–770.
   PubMed Web of Science ®Google Scholar
• Birlik B, Obuz F, Elibol FD, et al. Diffusion-weighted MRI and MI-volumetry – in the evaluation of tumour response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer. Magn Reson Imaging. 2015;33(2):201–212. .
   PubMed Web of Science ®Google Scholar
• De Cecco CN, Ganeshan B, Ciolina M, et al. Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance. Invest Radiol. 2015;50(4):239–245.
   Google Scholar
• Intven M, Reerink O, Philippens ME. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation. J Magn Reson Imaging. 2015;41(6):1646–1653.
   PubMed Web of Science ®Google Scholar
• Blazic I, Maksimovic R, Gajic M, et al. Apparent diffusion coefficient measurement covering complete tumour area predicts rectal cancer response to neoadjuvant chemoradiotherapy. Croat Med J. 2015;56(5):460–469.
   PubMed Web of Science ®Google Scholar
• Doi H, Beppu N, Kato T, et al. Diffusion-weighted magnetic resonance imaging for prediction of tumour response to neoadjuvant chemoradiotherapy using irinotecan plus S-1 for rectal cancer. Mol Clin Oncol. 2015;3(5):1129–1134. .
   PubMed Web of Science ®Google Scholar
• Ippolito D, Fior D, Trattenero C, et al. Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer. World J Radiol. 2015;7(12):509–520.
   PubMed Web of Science ®Google Scholar
• Lambregts DMJ, Rao SX, Sassen S, et al. MRI and diffusion-weighted MRI volumetry for identification of complete tumor responders after preoperative chemoraditherapy in patients with rectal cancer: a bi-institutional validation study. Ann Surg. 2015;262(6):1034–1039. .
   PubMed Web of Science ®Google Scholar
• Martens MH, Subhani S, Heijnen LA, et al. Can perfusion MRI predict response to preoperative treatment in rectal cancer? Radiother Oncol. 2015;114(2):218–223. .
   PubMed Web of Science ®Google Scholar
• Seierstad T, Hole KH, Groholt KK, et al. MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer. Br J Radiol. 2015;88(1051):20150097. .
   PubMed Web of Science ®Google Scholar
• Tong T, Sun Y, Gollub MJ, et al. Dynamic contrast-enhanced MRI: use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer. J Magn Reson Imaging. 2015;42(3):673–680.
   PubMed Web of Science ®Google Scholar
• Nougaret S, Vargas HA, Lakhman Y, et al. Intravoxel incoherent motion-derived histogram metric for assessment of response after combined chemotherapy and radiation therapy in rectal cancer: initial experience and comparison between single-section and volumetry analyses. Radiology. 2016;280(2):446–454. .
   PubMed Web of Science ®Google Scholar
• Choi MH, Oh SN, Rha SE, et al. Diffusion-weighted imaging: apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer. J Magn Reson Imaging. 2016;44(1):212–220. .
   PubMed Web of Science ®Google Scholar
• De Cecco CN, Ciolina M, Caruso D, et al. Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience. Abdom Radiol. 2016;41(9):1728–1735. .
   PubMed Web of Science ®Google Scholar
• Foti PV, Privitera G, Piana S, et al. Locally advanced rectal cancer; qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy. Eur J Radiol Open. 2016;3:145–152.
   PubMed Web of Science ®Google Scholar
• Iannicelli E, Di Pietropaolo D, Pilozzi E, et al. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predictin the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy. Abdom Radiol. 2016;41(10):1906–1917. .
   PubMed Web of Science ®Google Scholar
• Quaia E, Gennari AG, Ricciardi MC, et al. Value of percent change in tumoral volume measured at T2-weighted and diffusion-weighted MRI to identify responders after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer. J Magn Reson Imaging. 2016;44(6):1415–1424.
   PubMed Web of Science ®Google Scholar
• Jacobs L, Intven M, van Lelyveld N, et al. Diffusion-weighted MRI for early prediction of treatment response on preoperative chemoradiotherapy for patients with locally advanced rectal cancer: a feasibility study. Ann Surg. 2016;263(3):522–528. .
   PubMed Web of Science ®Google Scholar
• Sathyakumar K, Chandramohan A, Asih D, et al. BestMRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer. Br J Radiol. 2016;89(1060):20150328.
   PubMed Web of Science ®Google Scholar
• Chen YG, Chen MQ, Guo YY, et al. Apparent diffusion coefficient predicts pathology complete response of rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS One. 2016;11(4):e0153944. .
   PubMed Web of Science ®Google Scholar
• Nie K, Shi L, Chen Q, et al., Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin Cancer Res. 22(21): 5264–5265. 2016. .
   Web of Science ®Google Scholar
• Attenberger UI, Ong MM, Rathmann N, et al. mMRI a 3.0 T as an evaluation tool of therapeutic response to neoadjuvant CRT in patients with advanced-stage rectal cancer. Anticancer Res. 2017;37(1):215–222. .
   PubMed Web of Science ®Google Scholar
• De Felice F, Magnante AL, Musio D, et al. Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Eur J Surg Oncol. 2017;43(7):1324–1329. .
   PubMed Web of Science ®Google Scholar
• Van Heeswijk MM, Lambregts DMJ, Maas M, et al. Measuring the apparent diffusion coefficient in primary rectal tumours: is there a benefit in performing histogram analyses? Abdom Radiol. 2017;42(6):1627–1636. .
   PubMed Web of Science ®Google Scholar
• Zhu HB, Zhang XY, Zhou XH, et al. Assessment of pathological complete response to preoperative chemoradiotherapy by means of multiple mathematical models of diffusion-weighted MRI in locally advanced rectal cancer: a prospective single-center study. J Magn Reson Imaging. 2017;175–183. Doi:10.1002/jmri.25567.
   PubMed Web of Science ®Google Scholar
• Meng Y, Zhang C, Zou S, et al., MRI texture analysis in predicting treatment response to neoadjuvant chemoradiotherapy in rectal cancer. Oncotarget. 9(15): 11999–12008. 2017. .
   PubMedGoogle Scholar
• Bakke KM, Hole KH, Dueland S, et al. Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival. Acta Oncol. 2017;56(6):813–818. .
   PubMed Web of Science ®Google Scholar
• Hsu CY, Wang CW, Kuo CC, et al. Tumour compactness improves the preoperative volumetry-based prediction of the pathological complete response of rectal cancer after preoperative concurrent chemoradiotherapy. Oncotarget. 2017;8(5):7921–7934. .
   PubMedGoogle Scholar
• Zhang C, Ye F, Liu Y, et al. Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.. Oncotarget. 2018;9(4):4862–4874.
   PubMedGoogle Scholar
• Hu F, Tang W, Sun Y, et al. The value of diffusion kurtosis imaging in assessing pathological complete response to neoadjuvant chemoradiation therapy in rectal cancer: a comparison with conventional diffusion-weighted imaging. Oncotarget. 2017;8(43):75597–75606. .
   PubMedGoogle Scholar
• Yu J, Xu Q, Song JC, et al. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol. 2017;27(5):1848–1857. .
   PubMed Web of Science ®Google Scholar
• Chidambaram B, Brierley JD, Cummings B, et al. Investigation of volumetric apparent diffusion coefficient histogram analysis for assessing complete response and clinical outcomes following pre-operative chemoradiation treatment for rectal carcinoma. Abdom Radiol. 2017;42(5):1310–1318. .
   PubMed Web of Science ®Google Scholar
• Blazic IM, Lilic GB, Gajic MM. Quantitative assessment of rectal cancer response to neoadjuvant combined chemotherapy and radiation therapy: comparison of three methods of positioning region of interest for ADC measurements at diffusion-weighted MR imaging. Radiology. 2017;282(2):418–428.
   PubMed Web of Science ®Google Scholar
• Lu W, Jing H, Ju-Mei Z, et al. Intravoxel incoherent motion diffusion-weighted imaging for discriminating the pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Sci Rep. 2017;7(1):8496. .
   PubMedGoogle Scholar
• Liu Z, Zhang XY, Shi YJ, et al. Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clin Cancer Res. 2017;23(23):7253–7262. .
   PubMed Web of Science ®Google Scholar
• Liu M, Lv H, Liu LH, et al. Locally advanced rectal cancer: predicting non-responders to neoadjuvant chemoradiotherapy using apparent diffusion coefficient textures. Int J Colorectal Dis. 2017;32(7):1009–1012. .
   PubMed Web of Science ®Google Scholar
• Joye I, Debucquoy A, Deroose CM, et al. Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer. Radiother Oncol. 2017;124(1):104–109. .
   PubMed Web of Science ®Google Scholar
• Yeo DM, Oh SN, Choi MH, et al. Histogram analysis of perfusion parameters from dynamic contrast-enhanced MR imaging with tumor characteristics and therapeutic response in locally advanced rectal cancer. Biomed Res Int. 2018;2018:3724393.
   PubMed Web of Science ®Google Scholar
• Tarallo N, Angeretti MG, Bracchi E, et al. Magnetic resonance imaging in locally advanced rectal cancer: quantitative evaluation of the complete response to neoadjuvant therapy. Pol J Radiol. 2018;83:e600–e609.
   PubMed Web of Science ®Google Scholar
• Fiorino C, Gumina C, Passoni P, et al. A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer. Radiother Oncol. 2018;128(3):564–568. .
   PubMed Web of Science ®Google Scholar
• Krishan S, Patel A, Sud R, et al. Rectal perfusion parameters normalised to tumour-free rectal wall can predict response to neoadjuvant chemoradiotherapy. Clin Radiol. 2018;73(2):151–157. .
   PubMed Web of Science ®Google Scholar
• Dinapoli N, Barbaro B, Gatta R, et al., Magnetic resonance, vendor-independent, intensity-histogram analysis predicting pathological complete response after radiochemotherapy of rectal cancer. Int J Radiat Oncol Biol Phys. 102(4): 765–774. 2018. .
   PubMed Web of Science ®Google Scholar
• Cusumano D, Dinapoli N, Boldrini L, et al., Fractal-based radiomic approach to predict complete pathological response after chemo-radiotherapy in rectal cancer. Radiol Med. 123(4): 286–295. 2018. .
   PubMed Web of Science ®Google Scholar
• Giannini V, Mazzetti S, Bertotto I, et al., Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features. Eur J Nucl Med Mol Imaging. 46(4): 878–888. 2019. .
   PubMed Web of Science ®Google Scholar
• Palmisano A, Esposito A, Rancoita PMV,  et al. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be useful to predict rectal cancer sensitivity to chemoradiotherapy? Clin Radiol. 2018;73(10):911.e1-911.e7. .
   Web of Science ®Google Scholar
• Palmisano A, Esposito A, Di Chiara A, et al. Could early tumour volume changes assessed on morphological MRI predict the response to chemoradiation therapy in locally-advanced rectal cancer? Clin Radiol. 2018;73(6):555–563. .
   PubMed Web of Science ®Google Scholar
• Enkhbaatar NE, Inoue S, Yamamuro H, et al. MR imaging with apparent diffusion coefficient histogram analysis: evaluation of locally advanced rectal cancer after chemotherapy and radiation therapy. Radiology. 2018;288(1):129–137. .
   PubMed Web of Science ®Google Scholar
• Xu B, Chen Y, Guo Y, et al. Pretreatment tumour thickness as a predictor of pathologic complete response to neoadjuvant chemoradiation therapy for stage II/III rectal adenocarcinoma. Am J Clin Oncol. 2018;61(6):601–606.
   Google Scholar
• Cui Y, Yang X, Shi Z, et al., Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol. 29(3): 1211–1220. 2019. .
   PubMed Web of Science ®Google Scholar
• Zhou X, Yi Y, Liu Z, et al., Radiomics-based pretherapeutic prediction of non-response to neoadjuvant therapy in locally advanced rectal cancer. Ann Surg Oncol. 26(6): 1676–1684. 2019. .
   PubMed Web of Science ®Google Scholar
• Shu Z, FangS Ye Q et al. Prediction of efficacy of neoadjuvant chemoradiotherapy for rectal cancer: the value of texture analysis of magnetic resonance images. Abdom Radiol. 2019;Doi:10.1007/s00261-019-01971-y. [Epub ahead of print] 11
   PubMed Web of Science ®Google Scholar
• Liu S, Wen L, Hou J, et al. Predicting the pathological response to chemoradiotherapy of non-mucinous rectal cancer using pretreatment texture features based on intravoxel incoherent motion diffusion-weighted imaging. Abdom Radiol. 2019;44(8):2689–2698. .
   PubMed Web of Science ®Google Scholar
• Shayesteh SP, Alikhassi A, Fard Esfahani A, et al. Neo-adjuvant chemoradiotherapy response prediction using MRI based ensemble learning method in rectal cancer patients. Phys Med. 2019;62:111–119.
   PubMed Web of Science ®Google Scholar
• Ciolina M, Caruso D, De Santis D, et al. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment. Radiol Med. 2019;124(5):331–338. .
   PubMed Web of Science ®Google Scholar
• Cao W, Li Z, Mohamoud A, et al. Quantitative MRI assessment of mucinous rectal adenocarcinoma to predict tumour response after neoadjuvant therapy. Clin Radiol. 2019;74(4):278–286. .
   PubMed Web of Science ®Google Scholar
• Tang Z, Zhang XY, Liu Z, et al. Quantitative analysis of diffusion weighted imaging to predict pathological good response to neoadjuvant chemoradiation for locally advanced rectal cancer. Radiother Oncol. 2019;132:100–108.
   PubMed Web of Science ®Google Scholar
• Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1):19–23.
   PubMed Web of Science ®Google Scholar
• Mandard A-M, Dalibard F, Mandard J-C, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73(11):2680–2686. .
   PubMed Web of Science ®Google Scholar
• Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981;47(1):207–214.
   PubMed Web of Science ®Google Scholar
• Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47(2):141–146. .
   PubMed Web of Science ®Google Scholar
• Edge SB, Byrd DR, Compton CC, et al. 3rd . AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2010.
   Google Scholar
• Bouzourene H, Bosman FT, Seelentag W, et al. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer. 2002;94(4):1121–1130. .
   PubMed Web of Science ®Google Scholar
• Rodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23:8688–8696.
   PubMed Web of Science ®Google Scholar
• The Japanese Breast Cancer Society. General rules for clinical and pathological recording of breast cancer. 17th ed. Tokyo, Japan: Kanehara Shuppan; 2012.
   Google Scholar
• Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal Carcinoma. Tokyo: Kanehara; 1997.
   Google Scholar
• Meng Y, Wan L, Ye F, et al. MRI morphologic and clinicopathologic characteristics for predicting outcomes in patients with locally advanced rectal cancer. Abdom Radiol. 2018 Nov 19;Doi:10.1007/s00261-018-1828-1. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Jean SH, Song C, Chie EK, et al. Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer. Radiat Oncol. 2019;14(1):43. .
   PubMedGoogle Scholar
• Petrillo A, Fusco R, Granata V, et al. MR imaging perfusion and diffusion analysis to assess preoperative Short Course Radiotherapy response in locally advanced rectal cancer: standardized Index of Shape by DCE-MRI and intravoxel incoherent motion-derived parameters by DW-MRI. Med oncol.. 2017;34(12):198.
   Google Scholar
• Boldrini L, Cusumano D, Chiloiro G, et al. Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalised medicine approach. Radiol Med. 2019;124(2):145–153.
   Google Scholar
• Barbaro B, Fiorucci C, Tebala C, et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology. 2009;250(3):730–739.
   PubMed Web of Science ®Google Scholar